Accendra Health, Inc. ACH

0.71 (0.02) (2.74%) as of 25 Sep
Market cap
$59.2M
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Net Income
108.79 72.79 (437.01) (62.37) 29.87 221.59 22.39 (41.30) (362.69) (1,100.64)
Depreciation & Amortization
55.39 59.44 541.54 116.68 93.34 90.62 228.67 210.37 488.39 214.52
Non Cash Items (Other)
16.64 (35.40) (9.21) 44.26 132.28 56.87 (31.63) 424.45 4.10 709.39
Accounts Receivable Change
(25.24) (100.01) 11.11 63.53 (34.82) (2.20) 4.42 (8.99) (3.68) 122.36
Change in inventories
22.59 (57.03) (65.45) 127.92 (85.15) (263.44) 166.56 (5.35) (4.59) (6.85)
Accounts Payable Change
43.43 143.95 92.18 (235.63) 193.24 3.55 13.65 5.25 66.89 6.48
Change in other assets and liabilities
(37.56) (33.26) (23.60) 102.20 3.60 2.16 (91.19) 146.48 (34.55) (56.04)
Other operating activities
3.66 6.30 6.04 9.50 6.87 15.03 12.14 9.81 7.61 9.00
Operating Cash Flow
187.70 56.77 115.59 166.09 339.22 124.18 325.01 740.71 161.50 (101.79)
Capital expenditures
(14.93) (33.95) (43.18) (42.42) (50.42) (40.98) (109.71) (100.80) (100.36) (112.99)
Change in intangibles (net)
(9.82) (16.12) (20.81) (9.81) (8.77) (8.70) (8.49) (6.16) (12.38) (10.37)
Net Aquisitions
— (366.57) (751.83) — 133.00 — (1,684.61) — — 324.26
Other investing activities
(7.53) (8.72) (7.22) 0.33 6.27 (3.94) (1.67) (30.30) (3.79) (56.48)
Investing cash flow
(24.75) (416.64) (815.83) (51.90) 80.07 (53.63) (1,804.48) (137.25) (116.53) 144.42
Repayment/Issuance of Debt (Net)
— 351.48 785.00 (117.79) (536.87) (81.44) 1,582.50 (416.69) (244.20) 203.50
Equity Repurchase (Common, Net)
(71.03) (5.00) — — 189.97 — — — — (10.18)
Dividends Paid (Total)
(63.38) (63.15) (48.20) (5.23) (0.65) (0.73) — — — —
Other financial activities
(8.29) (10.52) (35.73) (7.18) (31.84) (47.31) (85.39) (0.64) (23.41) (5.24)
Financing cash flow
(142.70) 272.81 701.07 (130.20) (379.39) (129.48) 1,497.11 (417.33) (267.60) 188.08
Exchange Rate Adjustment
4.22 6.10 (1.99) (2.67) 9.91 (3.54) (3.48) 0.61 (0.90) 1.90
Change in Cash
24.47 (80.97) (1.15) (18.68) 49.82 (62.47) 14.15 186.74 (223.54) 232.61
Beginning Cash
161.02 185.49 104.52 103.37 84.69 134.51 72.04 86.19 272.92 49.38
Ending Cash
185.49 104.52 103.37 84.69 134.51 72.04 86.19 272.92 49.38 281.99
Stock Based Compensation
12.04 11.91 16.38 15.80 20.01 25.02 20.99 14.40 16.64 12.87
Dividends Paid (Common)
(63.38) (63.15) (48.20) (5.23) (0.65) (0.73) 0.00 0.00 0.00 0.00
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
3.22 (46.36) 14.23 58.02 76.87 (259.94) 93.44 137.38 24.07 65.94
Issuance/Purchase of Shares
(71.03) (5.00) — — 189.97 — — — — (10.18)
Other line items
Revenue per Employee
1.23 1.08 0.53 0.60 0.45 0.57 0.44 0.11 0.12 0.42

Fold the line items

In millions of $ except per-share values · columns are period end dates